{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:58:56Z","timestamp":1790330336099,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"Abstract<\/jats:title>\n \n Objective:<\/jats:title>\n \n To characterize correlations (\u03c1) between imaging and patient-related parameters in [\n 18<\/jats:sup>\n F] F-prostate-specific membrane antigen (PSMA)-1007 and [\n 68<\/jats:sup>\n Ga] Ga-PSMA-11 positron emission tomography-computed tomography (PET-CT) and to determine whether observed differences influence clinical tracer interchangeability.\n <\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n Two retrospective PET-CT cohorts from a single-center database were analyzed, comprising patients imaged for suspected prostate cancer with either tracer. Spearman rank intra-tracer correlation coefficients were calculated between weight, body surface area (BSA), lean body mass (LBM), lesion maximum standardized uptake value (SUVmax) (T), liver mean SUV (SUVmean) (B), tumor-to-background ratio (T\/B), and metabolic tumor volume. Inter-tracer comparisons were performed using Fisher-transformed paired correlation coefficients, with Bonferroni correction to control type I error.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Mann\u2013Whitney testing demonstrated no significant differences in weight (\n P<\/jats:italic>\n = 0.50), BSA (\n P<\/jats:italic>\n = 0.50), or LBM (\n P<\/jats:italic>\n = 0.47) distributions between cohorts. Intra-tracer heatmaps showed broadly similar correlation patterns and significance distributions across tracers. Inter-tracer analysis identified significant differences in correlations between liver SUVmean with weight (\u03c1 = 0.43,\n P<\/jats:italic>\n = 0.0001), BSA (\u03c1 = 0.29,\n P<\/jats:italic>\n = 0.0001), and LBM (\u03c1 = 0.29,\n P<\/jats:italic>\n = 0.0001). These differences were nullified when standard weight-based liver SUVmean normalization for [\n 68<\/jats:sup>\n Ga] Ga-PSMA-11 was replaced with LBM normalization (weight: \u03c1 = \u22120.01,\n P<\/jats:italic>\n = 0.96; BSA: \u03c1 = \u22120.04,\n P<\/jats:italic>\n = 0.75; LBM: \u03c1 = \u22120.04,\n P<\/jats:italic>\n = 0.75) or BSA normalization (weight: \u03c1 = \u22120.09,\n P<\/jats:italic>\n = 0.49; BSA: \u03c1 = \u22120.12,\n P<\/jats:italic>\n = 0.36; LBM: \u03c1 = \u22120.12,\n P<\/jats:italic>\n = 0.36).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Correlation structures for the two tracers were broadly comparable across most imaging and demographic variables. Observed differences in liver SUVmean correlations with body habitus parameters were mitigated by BSA or LBM normalization. These findings support clinical tracer interchangeability. However, full characterization is recommended when alternative SUV normalizations are applied or when liver SUVmean is used as background reference tissue in tumor-to-background trial selection criteria.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jmp.jmp_56_26","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:55Z","timestamp":1790168455000},"page":"672-679","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["[18F]F-Prostate-specific Membrane Antigen-1007 and [68Ga] Ga-Prostate-specific Membrane Antigen-11 Positron Emission Tomography in Prostate Cancer: Do Standardized Uptake Value Correlations Dictate Choice?"],"prefix":"10.4103","volume":"51","author":[{"given":"Bal","family":"Sanghera","sequence":"first","affiliation":[{"name":"Barts Health NHS Trust, St. Bartholomew\u2019s Hospital, West Smithfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Lowe","sequence":"additional","affiliation":[{"name":"Physics Department, Mount Vernon Hospital, East and North Herts NHS Trust, Stevenage, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sanghera","sequence":"additional","affiliation":[{"name":"Nuclear medicine, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Lup","family":"Wong","sequence":"additional","affiliation":[{"name":"Paul Strickland Scanner Centre, East and North Herts NHS Trust, Stevenage, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"R1-20260925","first-page":"164","article-title":"Standardized uptake values of FDG: Body surface area correction is preferable to body weight correction","volume":"35","author":"Kim","year":"1994","journal-title":"J Nucl Med"},{"key":"R2-20260925","first-page":"1836","article-title":"SUV: Standard uptake or silly useless value?","volume":"36","author":"Keyes","year":"1995","journal-title":"J Nucl Med"},{"key":"R3-20260925","doi-asserted-by":"crossref","first-page":"102584","DOI":"10.1016\/j.ejmp.2023.102584","article-title":"Impact of patient\u2019s habitus on image quality and quantitative metrics in 18F-FDG PET\/CT images","volume":"109","author":"Zorz","year":"2023","journal-title":"Phys Med"},{"key":"R4-20260925","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40658-021-00363-w","article-title":"Evaluation of SUVlean consistency in FDG and PSMA PET\/MR with Dixon-, James-, and Janma-based lean body mass correction","volume":"8","author":"Zhao","year":"2021","journal-title":"EJNMMI Phys"},{"key":"R5-20260925","doi-asserted-by":"crossref","first-page":"1368093","DOI":"10.3389\/fmed.2024.1368093","article-title":"Agreement between PSMA-RADS and E-PSMA systems in classifying [(18)F]PSMA-1007 PET\/CT lesions among prostate cancer patients: Exploring the correlation between lesion size and uptake","volume":"11","author":"Mendoza-\u00c1vila","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R6-20260925","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4274\/mirt.galenos.2021.59254","article-title":"Is SUV corrected for lean body mass superior to SUV of body weight in (68)Ga-PSMA PET\/CT?","volume":"30","author":"Aksu","year":"2021","journal-title":"Mol Imaging Radionucl Ther"},{"key":"R7-20260925","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13550-019-0572-z","article-title":"Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET\/CT: A bi-centric analysis","volume":"9","author":"Gafita","year":"2019","journal-title":"EJNMMI Res"},{"key":"R8-20260925","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13550-024-01097-3","article-title":"Evaluating the biodistribution for [(68)Ga]Ga-PSMA-11 and [(18)F]F-PSMA-1007 PET\/CT with an inter- and intrapatient based analysis","volume":"14","author":"Popescu","year":"2024","journal-title":"EJNMMI Res"},{"key":"R10-20260925","first-page":"35","article-title":"Quantitative characterization of (18)F-PSMA-1007 and [(68)Ga]Ga-PSMA-11 PET-CT imaging in suspected prostate cancer: A single-centre experience","volume":"35","author":"Sanghera","year":"2026","journal-title":"Mol Imaging Radionucl Ther"},{"key":"R11-20260925","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","article-title":"Comparison of (18)F-based PSMA radiotracers with [(68)Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer-a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R13-20260925","first-page":"507","article-title":"Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population","volume":"10","author":"Fisher","year":"1915","journal-title":"Biometrika"},{"key":"R14-20260925","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","article-title":"[(68)Ga]Ga-PSMA versus [(18)F]PSMA positron emission tomography\/computed tomography in the staging of primary and recurrent prostate cancer. A systematic review of the literature","volume":"5","author":"Evangelista","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"R15-20260925","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s00259-025-07104-6","article-title":"Improving accuracy of SUV estimates in paediatric oncology: Recommending against the use of body weight corrected SUV in [(18)F]FDG PET","volume":"52","author":"de Vries","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20260925","doi-asserted-by":"crossref","first-page":"1238333","DOI":"10.3389\/fmed.2023.1238333","article-title":"An exploratory study of unexplained concentration of (18)F-PSMA-1007 in the bladder for prostate cancer PET\/CT imaging","volume":"10","author":"Dang","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R17-20260925","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/ph17111458","article-title":"Different PSMA radiopharmaceuticals: A comparative study of [(18)F]F-PSMA-1007, [(18)F]F-JK-PSMA-7, and [(99m)Tc] Tc-PSMA-I and S in the skeletal system","volume":"17","author":"Mik\u00f3","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"R18-20260925","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.3390\/cancers14205141","article-title":"Time after synthesis and time after injection do not affect diagnostic quality of [(18)F]F-PSMA 1007 PET","volume":"14","author":"Relt","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R19-20260925","doi-asserted-by":"crossref","first-page":"e70016","DOI":"10.1111\/cpf.70016","article-title":"Evaluation of [18F]PSMA-1007 uptake variability in patients with prostate cancer","volume":"45","author":"Tr\u00e4g\u00e5rdh","year":"2025","journal-title":"Clin Physiol Funct Imaging"},{"key":"R20-20260925","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cpf.12785","article-title":"Biokinetics and dosimetry of (18)F-PSMA-1007 in patients with prostate cancer","volume":"42","author":"Hvittfeldt","year":"2022","journal-title":"Clin Physiol Funct Imaging"},{"key":"R21-20260925","first-page":"1124","article-title":"Tumor sink effect: Myth or reality?","volume":"63","author":"Gafita","year":"2022","journal-title":"J Nucl Med"},{"key":"R22-20260925","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40644-025-00910-z","article-title":"The tumour sink effect on 68Ga-PSMA-PET\/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: A sub-analysis of the 3TMPO study","volume":"25","author":"Zamanian","year":"2025","journal-title":"Cancer Imaging"},{"key":"R23-20260925","doi-asserted-by":"crossref","first-page":"e0324457","DOI":"10.1371\/journal.pone.0324457","article-title":"Pain in the brain: Psychological correlates of chronic pain and fibromyalgia","volume":"20","author":"Passarelli","year":"2025","journal-title":"PLoS One"},{"key":"R24-20260925","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-023-01874-5","article-title":"Comparison of PET\/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy","volume":"38","author":"Michalski","year":"2024","journal-title":"Ann Nucl Med"},{"key":"R25-20260925","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: Joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_56_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:01:13Z","timestamp":1790326873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_56_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_56_26","relation":{},"ISSN":["0971-6203","1998-3913"],"issn-type":[{"value":"0971-6203","type":"print"},{"value":"1998-3913","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}